A First Human Dose Study to Investigate Safety and Tolerability of LY2979165 in Healthy Volunteers

Summary

This is a two part study (Parts A and B), the purpose of which is to determine the safety of LY2979165 in healthy people, and any side effects that might be associated with it, and to understand how the body handles LY2979165. In addition, Part B, will also look at levels of LY2979165 in spinal fluid. Doses investigated will be in the range of 20-1000 mg.

Timeline

Start

2010-11

Primary completion

2011-05

Completion

2011-05

Drugs

Indications